1Allen J,Thomson JD,Lewis IJ,et al.Mitral regurgitation after anthracycline treatment for childhood malignancy[J].Heart,2001,85(4):430-452.
2Fukumi D,Uchikoba Y,Maeda M,et al.Longitudinal evaluation of anthracycline cardiotoxicity by signal-averaged electrocardiography in children with cancer[J].Pediatr Int,2002,44(2):134-140.
3Sung RY,Huang GY,Shing MK,et al.Echocardiographic evaluation of cardiac function in paediatric oncology patients treated with or without anthracycline[J].Int J Cardiol,1997,60(3):239-248.
4Hashimoto I,Ichida F,Miura M,et al.Automatic border detection identifies subclinical anthracycline cardiotoxicity in children with malignancy[J].Circulation,1999,99(18):2367-2370.
5Kapusta L,Groot-Loonen J,Thijssen JM,et al.Regional cardiac wall motion abnormalities during and shortly after anthracyclines therapy[J].Med Pediatr Oncol,2003,41(5):426-435.
6Elbl L,Hrstkova H,Chaloupka V,et al.The evaluation of left ventricular function in childhood cancer survivors by pharmacological stress echocardiography[J].Neoplasma,2003,50(3):191-197.
7Mitani I,Jain D,Joska TM,et al.Doxorubicin cardiotoxicity:prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era[J].J Nucl Cardiol,2003,10(2):132-139.
8Suzuki J,Yanagisawa A,Shiqeyama T,et al.Early detection of anthracycline- induced cardiotoxicity by radionuclide angiocardiography[J].Angiology,1999,50(1):37-45.
9Mohammad GI,Al-Menshawy AM,Abd El-Hakeem EE,et al.The value of biochemical markers in evaluation of myocardial damage in children[J].Eg J Anaesth,2003, 19(1):1-8.
10Kremer LC,Bastiaansen BA,Offringa M,et al.Troponin T in the first 24 hours after the administration of chemotherapy and the detection of myocardial damage in children[J].Eur J Cancer,2002,38(5):686-689.
